[topsearch__bar__shortcode]

December 2, 2020

KOSS Stock

Ovid Therapeutics Inc. (OVID) shares nosedived as the trials missed targets

Leave a Comment / Featured /

Ovid Therapeutics Inc. (NASDAQ: OVID) stock plunged 49.77% to 3.34 in the after-market session following the biotech corporation dedicated to developing therapies that change the lives of people with rare neurological disorders, officially revealed the findings of the Company’s Phase 3 NEPTUNE clinical trial of OV101 (gaboxadol) for the treatment of Angelman syndrome. The primary endpoint of […]

Ovid Therapeutics Inc. (OVID) shares nosedived as the trials missed targets Read More »

ALLG Stock

Mesobllast ltd. (NASDAQ: MESO) bursting in the after-market session

Leave a Comment / Featured /

Mesobllast ltd. (MESO) the stock was flying as high as 10.12% in the post-market session on December 1, 2020, even after it was reported that Frank R. Cruz’s Law Office advises clients that class action cases have been brought on behalf of the owners of the following publicly listed firms. Investors have until the time limits set

Mesobllast ltd. (NASDAQ: MESO) bursting in the after-market session Read More »

NEXO Stock

ZomedicaCorp. (ZOM) shares spiked in the after-market session

Leave a Comment / Featured /

ZomedicaCorp. (NYSE: ZOM) stock jumped 14.46% to 0.205 in the after-market session. Yet, there does notseem to be any company-specific news that has prompted Ideanomics’ share priceto increase today, and investors will want to take that as a warning sign. Nevertheless, on November 12, 2020, the firm with the marketcapitalization of 101.02M officially posted consolidated financial reports

ZomedicaCorp. (ZOM) shares spiked in the after-market session Read More »

RZLT Stock

iBio, Inc. ( IBIO) rising above the horizon at the aftermarket trading

Leave a Comment / Featured /

A biotech innovative and manufacturing company, iBio, Inc. (NYSE: IBIO) shares soared 17.93% in the aftermarket trading on Tuesday, December 1, 2020, after the company officially announced that it has entered into its first declaration of work to manufacture its bioengineered antibody-toxin fusion proteins using the FastPharming Method of iBio under a Master Services Arrangement

iBio, Inc. ( IBIO) rising above the horizon at the aftermarket trading Read More »

Stocks
Telegraph

At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.

About

Categories

Social Links

Facebook Twitter Youtube Instagram Linkedin